Takeda Pharmaceutical Co., Ltd./ US8740602052 /
12/21/2018 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
16.5900USD | - | 7.86 mill. Turnover: - |
-Bid Size: - | -Ask Size: - | 48.82 bill.USD | - | - |
GlobeNewswire
10/16/2019
Global RNA-Targeted Small Molecules Study, 2019: A Landscape Analysis of Companies, Technologies, Ta...
GlobeNewswire
7/10/2019
Worldwide Proton Pump Inhibitors (PPIs) Markets to 2023 with AstraZeneca, Bayer, Johnson & Johnson S...
GlobeNewswire
6/28/2019
Global Pericarditis Drugs Market Research Report 2019-2023 - Key Players are AstraZeneca, Bayer, Joh...
GlobeNewswire
6/18/2019
White Oil: $2.71Bn World Market Insights & Outlook to 2025 with Sonneborn, Sinopec, Nynas, Royal Dut...
GlobeNewswire
4/25/2019
Integrin Alpha 4 Therapeutics Pipeline Report, H1 2019 - Review of 9 Companies, Drug Profiles & Feat...
GlobeNewswire
4/8/2019
World Primary Immune Deficiency (PID) Therapeutics Pipeline Report, H1 2019 Edition with Review of K...
GlobeNewswire
1/31/2019
Gastrointestinal Diseases Pipeline Review, 2018 - Which Companies are the Most Active within Each Pi...
GlobeNewswire
1/21/2019
Global Women's Health Drugs Market Report 2019-2024 Featuring AbbVie Allergan Bayer, GlaxoSmithKline...
GlobeNewswire
12/17/2018
The Global Market for Cell Separation & Characterization in Solid Tumors (2018-2023): Abbvie, AstraZ...
GlobeNewswire
9/17/2018
World Vaccines (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, P...
GlobeNewswire
8/30/2018
Mesoblast Reports Fourth Quarter and Full-Year 2018 Financial Results and Operational Highlights